Clinical Trial

Investigation to Evaluate the Safety and Effectiveness of Cochlear Implantation in Children and Adults With Unilateral Hearing Loss/Single-sided Deafness

Study acronym: PAS-SSD
Recruiting
View on ClinicalTrials.gov →
Summary
The aim of the study is to assess the continued efficacy and safety of cochlear implantation in participants aged 5 years and above with Unilateral Hearing Loss (UHL)/Single Sided Deafness (SSD) supporting a change indication for use.
Protocol Amendment History 12 amendments
This ClinicalTrials.gov record has been amended 12 times since 2022-03-31; most recent amendment 2025-08-26.
Status change: Not Yet Recruiting → Recruiting 2022-08-10
Trial Details
NCT Number NCT05318417
Lead Sponsor Cochlear
Collaborators: NAMSA
Conditions Hearing Loss, Unilateral, Deafness, Unilateral
Enrollment 60 participants
Start Date 2022-08-19
Primary Completion 2027-05 (estimated)
Study Completion 2027-06 (estimated)
Updated on ClinicalTrials.gov 2025-09-02